Binay Shah, Co-Founder, President and CEO at Binaytara, shared Rupesh Mishra’s, Vice President at Rare Diseases Society Nepal (RDSN), post on LinkedIn, adding:
“It was wonderful to reconnect with Dr. Rupesh Mishra at our Lung Cancer Conference in Brooklyn!
Binaytara previously supported Dr. Mishra’s training – an investment in local expertise that has translated into meaningful, sustainable impact. After completing his training, he successfully established a genomic lab at Civil Service Hospital in Nepal, strengthening access to advanced cancer diagnostics locally.
Civil Service Hospital is also home to the bone marrow transplant center whose establishment Binaytara supported. Seeing leaders like Dr. Mishra continue to build capacity and advance cancer care is a powerful reminder of why investing in people, training, and healthcare infrastructure matters.
We were delighted to have him join us in Brooklyn and to see how a partnership that began with training continues to create impact years later.”
Quoting Rupesh Mishra’s post:
“A big thank you to Dr. Binay Shah and the entire Binaytara team for their incredible work and dedication to advancing oncology education and improving cancer care.
Binaytara Foundation has built a meaningful and growing presence in the in the oncology community through its extensive hematology and oncology educational programs, bringing together healthcare professionals from across the country and creating opportunities for learning, collaboration, and better patient care. A special thank you to Dr. Binay Shah for his leadership, vision, and continued commitment to making a difference in oncology. Truly grateful for all that you do and for the impact you continue to make in the oncology community.”
Other articles featuring Binay Shah and Binaytara on OncoDaily.
